-
June 5: The Week in Cancer NewsData show that some people with early-stage non-small cell lung cancer can benefit significantly from treatment with a targeted therapy, and COVID-19 slows the rate of enrollment in cancer clinical trials.
by Kate Yandell
-
May 29: The Week in Cancer NewsA study shows that a more tolerable, dose-adjusted chemotherapy regimen can effectively treat a rare lymphoma, and data from registries provide information on which cancer patients are at greatest risk of death from COVID-19.
by Kate Yandell
-
May 22: The Week in Cancer NewsA study finds that metastatic prostate cancer incidence rose after the U.S. Preventive Services Task Force urged against routine PSA testing, and the Food and Drug Administration approves two PARP inhibitors for treatment of prostate cancer.
by Kate Yandell
-
May 15: The Week in Cancer NewsA study indicates that children with cancer are not at increased risks of severe cases of COVID-19, and researchers find that Medicaid expansion was associated with reduced cancer deaths.
by Kate Yandell
-
May 8: The Week in Cancer NewsA study finds that opioid deaths have slightly increased among people with cancer, and the Food and Drug Administration approves a targeted therapy for non-small cell lung cancer.
by Kate Yandell
-
May 1: The Week in Cancer NewsAt the AACR Virtual Annual Meeting I, researchers presented new data on cancer biology, treatment, screening and risk reduction.
by Cancer Today Staff
-
April 24: The Week in Cancer NewsA third of cancer survivors report that they or their partners have stayed in jobs due to concerns about keeping health insurance, and the Food and Drug Administration approves a new treatment for metastatic triple-negative breast cancer.
by Kate Yandell
-
April 17: The Week in Cancer NewsA study shows that antibiotic use prior to starting immunotherapy for melanoma is associated with decreased survival, and the Food and Drug Administration approves a treatment for advanced HER2-positive breast cancer.
by Kate Yandell
-
April 10: The Week in Cancer NewsA study indicates that the rate of e-cigarette use is elevated in young adults with a history of cancer, and oncologists write about the impact of COVID-19.
by Kate Yandell
-
April 3: The Week in Cancer NewsCAR-T cell therapy shows promise for treating mantle cell lymphoma, and the Food and Drug Administration requests that drugmakers pull the anti-heartburn drug ranitidine due to concerns about a contaminant that may increase cancer risk.
by Kate Yandell
About half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
-
Pediatric Cancer’s AftershocksNew research highlights approaches that could provide better long-term quality of life for childhood cancer survivors.
-
What Are the Benefits of Exercise for Cancer Patients?Several recent studies have explored how exercise can impact a cancer patient’s survival, risk of recurrence, and overall quality of life.
Cancer Research at a Crossroads
